{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:02:55Z","timestamp":1793199775531,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yunnan Provincial Department of Science and Technology, Joint Specialized General Project","award":["202401AY070001-197"],"award-info":[{"award-number":["202401AY070001-197"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00203-026-05104-0","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:15:20Z","timestamp":1786425320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Helicobacter pylori promote M1 macrophage polarization via JAK3-mediated activation of the SOCS3\/IL2RA axis to suppress host immunity"],"prefix":"10.1007","volume":"208","author":[{"given":"Jian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5326-2415","authenticated-orcid":false,"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"issue":"3","key":"5104_CR1","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3349\/ymj.2015.56.3.862","volume":"56","author":"B Cha","year":"2015","unstructured":"Cha B, Lim JW, Kim H (2015) Jak1\/Stat3 is an upstream signaling of NF-\u03baB activation in Helicobacter pylori-induced IL-8 production in gastric epithelial AGS cells. Yonsei Med J 56(3):862\u2013866. https:\/\/doi.org\/10.3349\/ymj.2015.56.3.862","journal-title":"Yonsei Med J"},{"issue":"4","key":"5104_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","volume":"166","author":"YC Chen","year":"2024","unstructured":"Chen YC, Malfertheiner P, Yu HT et al (2024) Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022. Gastroenterology 166(4):605\u2013619. https:\/\/doi.org\/10.1053\/j.gastro.2023.12.022","journal-title":"Gastroenterology"},{"issue":"11","key":"5104_CR3","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.3390\/ijms25115856","volume":"25","author":"MP Dore","year":"2024","unstructured":"Dore MP, Pes GM (2024) Trained immunity and trained tolerance: the case of Helicobacter pylori\u00a0infection. Int J Mol Sci 25(11):5856. https:\/\/doi.org\/10.3390\/ijms25115856","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5104_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/mmi.14123","volume":"110","author":"V Dyer","year":"2018","unstructured":"Dyer V, Br\u00fcggemann H, S\u00f6rensen M et al (2018) Genomic features of the Helicobacter pylori strain PMSS1 and its virulence attributes as deduced from its in vivo colonisation patterns. Mol Microbiol 110(5):761\u2013776. https:\/\/doi.org\/10.1111\/mmi.14123","journal-title":"Mol Microbiol"},{"issue":"2","key":"5104_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/antibiotics12020191","volume":"12","author":"A Elbehiry","year":"2023","unstructured":"Elbehiry A, Marzouk E, Aldubaib M et al (2023) Helicobacter pylori infection: current status and future prospects on diagnostic, therapeutic and control challenges. Antibiot Basel Switz 12(2):191. https:\/\/doi.org\/10.3390\/antibiotics12020191","journal-title":"Antibiot Basel Switz"},{"key":"5104_CR6","doi-asserted-by":"publisher","first-page":"104019","DOI":"10.1016\/j.micpath.2020.104019","volume":"141","author":"S Eyvazi","year":"2020","unstructured":"Eyvazi S, Vostakolaei MA, Dilmaghani A et al (2020) The oncogenic roles of bacterial infections in development of cancer. Microb Pathog 141:104019. https:\/\/doi.org\/10.1016\/j.micpath.2020.104019","journal-title":"Microb Pathog"},{"issue":"12","key":"5104_CR7","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.3390\/v13122379","volume":"13","author":"IJ Ezeonwumelu","year":"2021","unstructured":"Ezeonwumelu IJ, Garcia-Vidal E, Ballana E (2021) JAK-STAT pathway. A novel target to tackle viral infections. Viruses 13(12):2379. https:\/\/doi.org\/10.3390\/v13122379","journal-title":"Viruses"},{"key":"5104_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1342913","author":"J Fan","year":"2024","unstructured":"Fan J, Zhu J, Xu H (2024) Strategies of Helicobacter pylori in evading host innate and adaptive immunity: insights and prospects for therapeutic targeting. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2024.1342913","journal-title":"Front Cell Infect Microbiol"},{"key":"5104_CR9","doi-asserted-by":"publisher","first-page":"1342913","DOI":"10.3389\/fcimb.2024.1342913","volume":"14","author":"J Fan","year":"2024","unstructured":"Fan J, Zhu J, Xu H (2024) Strategies of Helicobacter pylori in evading host innate and adaptive immunity: insights and prospects for therapeutic targeting. Front Cell Infect Microbiol 14:1342913. https:\/\/doi.org\/10.3389\/fcimb.2024.1342913","journal-title":"Front Cell Infect Microbiol"},{"issue":"29","key":"5104_CR10","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.3748\/wjg.v24.i29.3204","volume":"24","author":"AG Gravina","year":"2018","unstructured":"Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M (2018) Helicobacter pylori and extragastric diseases: a review. World J Gastroenterol 24(29):3204\u20133221. https:\/\/doi.org\/10.3748\/wjg.v24.i29.3204","journal-title":"World J Gastroenterol"},{"issue":"1","key":"5104_CR11","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1038\/s41467-025-59339-4","volume":"16","author":"W Hu","year":"2025","unstructured":"Hu W, Chen ZM, Wang Y et al (2025) Single-cell RNA sequencing dissects the immunosuppressive signatures in Helicobacter pylori-infected human gastric ecosystem. Nat Commun 16(1):3903. https:\/\/doi.org\/10.1038\/s41467-025-59339-4","journal-title":"Nat Commun"},{"issue":"3","key":"5104_CR12","doi-asserted-by":"publisher","first-page":"e13105","DOI":"10.1111\/hel.13105","volume":"29","author":"A Jafarzadeh","year":"2024","unstructured":"Jafarzadeh A, Jafarzadeh Z, Nemati M, Yoshimura A (2024) The interplay between Helicobacter pylori and suppressors of cytokine signaling (SOCS) molecules in the development of gastric cancer and induction of immune response. Helicobacter 29(3):e13105. https:\/\/doi.org\/10.1111\/hel.13105","journal-title":"Helicobacter"},{"issue":"3","key":"5104_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5306\/wjco.v13.i3.186","volume":"13","author":"V Lima de Souza Gon\u00e7alves","year":"2022","unstructured":"Lima de Souza Gon\u00e7alves V, Cordeiro Santos ML, Silva Luz M et al (2022) From Helicobacter pylori infection to gastric cancer: current evidence on the immune response. World J Clin Oncol 13(3):186\u2013199. https:\/\/doi.org\/10.5306\/wjco.v13.i3.186","journal-title":"World J Clin Oncol"},{"key":"5104_CR14","doi-asserted-by":"publisher","first-page":"1790936","DOI":"10.3389\/fimmu.2026.1790936","volume":"17","author":"Z Liu","year":"2026","unstructured":"Liu Z, Liu J, Chu H et al (2026) JAK inhibition in PD-1 immunotherapy and tumor microenvironment. Front Immunol 17:1790936. https:\/\/doi.org\/10.3389\/fimmu.2026.1790936","journal-title":"Front Immunol"},{"issue":"1","key":"5104_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41392-024-01934-w","volume":"9","author":"Y Lv","year":"2024","unstructured":"Lv Y, Qi J, Babon JJ et al (2024) The JAK-STAT pathway: from structural biology to cytokine engineering. Signal Transduct Target Ther 9(1):221. https:\/\/doi.org\/10.1038\/s41392-024-01934-w","journal-title":"Signal Transduct Target Ther"},{"issue":"17","key":"5104_CR16","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s00018-016-2234-x","volume":"73","author":"R Mahony","year":"2016","unstructured":"Mahony R, Ahmed S, Diskin C, Stevenson NJ (2016) SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use? Cell Mol Life Sci CMLS 73(17):3323\u20133336. https:\/\/doi.org\/10.1007\/s00018-016-2234-x","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"9","key":"5104_CR17","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","volume":"71","author":"P Malfertheiner","year":"2022","unstructured":"Malfertheiner P, Megraud F, Rokkas T et al (2022) Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report. Gut 71(9):1724\u20131762. https:\/\/doi.org\/10.1136\/gutjnl-2022-327745","journal-title":"Gut"},{"issue":"1","key":"5104_CR18","doi-asserted-by":"publisher","first-page":"101217","DOI":"10.1016\/j.lanmic.2025.101217","volume":"7","author":"FJ Mart\u00ednez-Mart\u00ednez","year":"2026","unstructured":"Mart\u00ednez-Mart\u00ednez FJ, Chiner-Oms \u00c1, Furi\u00f3 V et al (2026) Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study. Lancet Microbe 7(1):101217. https:\/\/doi.org\/10.1016\/j.lanmic.2025.101217","journal-title":"Lancet Microbe"},{"issue":"16","key":"5104_CR19","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.3748\/wjg.v24.i16.1725","volume":"24","author":"K Minaga","year":"2018","unstructured":"Minaga K, Watanabe T, Kamata K, Asano N, Kudo M (2018) Nucleotide-binding oligomerization domain 1 and Helicobacter pylori infection: a review. World J Gastroenterol 24(16):1725\u20131733. https:\/\/doi.org\/10.3748\/wjg.v24.i16.1725","journal-title":"World J Gastroenterol"},{"issue":"3","key":"5104_CR20","doi-asserted-by":"publisher","first-page":"bbaf241","DOI":"10.1093\/bib\/bbaf241","volume":"26","author":"SH Mohamed","year":"2025","unstructured":"Mohamed SH, Hamed M, Alamoudi HA, Jastaniah Z, Alakwaa FM, Reda A (2025) Multi-omics analysis of Helicobacter pylori-associated gastric cancer identifies hub genes as a novel therapeutic biomarker. Brief Bioinform 26(3):bbaf241. https:\/\/doi.org\/10.1093\/bib\/bbaf241","journal-title":"Brief Bioinform"},{"key":"5104_CR21","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1017\/erm.2023.17","volume":"25","author":"R Mohammadzadeh","year":"2023","unstructured":"Mohammadzadeh R, Menbari S, Pishdadian A, Farsiani H (2023) Helicobacter pylori virulence factors: subversion of host immune system and development of various clinical outcomes. Expert Rev Mol Med 25:e23. https:\/\/doi.org\/10.1017\/erm.2023.17","journal-title":"Expert Rev Mol Med"},{"key":"5104_CR22","doi-asserted-by":"publisher","first-page":"1393799","DOI":"10.3389\/fimmu.2024.1393799","volume":"15","author":"M Morelli","year":"2024","unstructured":"Morelli M, Madonna S, Albanesi C (2024) SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation. Front Immunol 15:1393799. https:\/\/doi.org\/10.3389\/fimmu.2024.1393799","journal-title":"Front Immunol"},{"key":"5104_CR23","doi-asserted-by":"publisher","first-page":"1254198","DOI":"10.3389\/fcimb.2023.1254198","volume":"13","author":"Y Peng","year":"2023","unstructured":"Peng Y, Ma Y, Luo Z, Jiang Y, Xu Z, Yu R (2023) Lactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms. Front Cell Infect Microbiol 13:1254198. https:\/\/doi.org\/10.3389\/fcimb.2023.1254198","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"5104_CR24","doi-asserted-by":"publisher","first-page":"e15018","DOI":"10.1371\/journal.pone.0015018","volume":"5","author":"M Quiding-J\u00e4rbrink","year":"2010","unstructured":"Quiding-J\u00e4rbrink M, Raghavan S, Sundquist M (2010) Enhanced M1 macrophage polarization in human Helicobacter pylori-associated atrophic gastritis and in vaccinated mice. PLoS One 5(11):e15018. https:\/\/doi.org\/10.1371\/journal.pone.0015018","journal-title":"PLoS One"},{"issue":"1","key":"5104_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12964-020-00655-1","volume":"18","author":"M Sarajlic","year":"2020","unstructured":"Sarajlic M, Neuper T, Vetter J et al (2020) H. pylori modulates DC functions via T4SS\/TNF\u03b1\/p38-dependent SOCS3 expression. Cell Commun Signal CCS 18(1):160. https:\/\/doi.org\/10.1186\/s12964-020-00655-1","journal-title":"Cell Commun Signal CCS"},{"issue":"5","key":"5104_CR26","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","volume":"155","author":"A Savoldi","year":"2018","unstructured":"Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E (2018) Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in world health organization regions. Gastroenterology 155(5):1372-1382e17. https:\/\/doi.org\/10.1053\/j.gastro.2018.07.007","journal-title":"Gastroenterology"},{"key":"5104_CR27","doi-asserted-by":"publisher","first-page":"1379209","DOI":"10.3389\/fmicb.2024.1379209","volume":"15","author":"N Shadvar","year":"2024","unstructured":"Shadvar N, Akrami S, Mousavi Sagharchi SMA et al (2024) A review for non-antibiotic treatment of Helicobacter pylori: new insight. Front Microbiol 15:1379209. https:\/\/doi.org\/10.3389\/fmicb.2024.1379209","journal-title":"Front Microbiol"},{"issue":"2","key":"5104_CR28","doi-asserted-by":"publisher","first-page":"e6959","DOI":"10.1002\/cam4.6959","volume":"13","author":"Z Shaopeng","year":"2024","unstructured":"Shaopeng Z, Yang Z, Yuan F, Chen H, Zhengjun Q (2024) Regulation of regulatory T cells and tumor-associated macrophages in gastric cancer tumor microenvironment. Cancer Med 13(2):e6959. https:\/\/doi.org\/10.1002\/cam4.6959","journal-title":"Cancer Med"},{"issue":"1","key":"5104_CR29","doi-asserted-by":"publisher","first-page":"25726","DOI":"10.1038\/s41598-024-77265-1","volume":"14","author":"JJ Shin","year":"2024","unstructured":"Shin JJ, Suk K, Lee WH (2024) LncRNA BRE-AS1 regulates the JAK2\/STAT3-mediated inflammatory activation via the miR-30b-5p\/SOC3 axis in THP-1 cells. Sci Rep 14(1):25726. https:\/\/doi.org\/10.1038\/s41598-024-77265-1","journal-title":"Sci Rep"},{"key":"5104_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2025.101470","author":"IS Sirit","year":"2025","unstructured":"Sirit IS, Peek RM (2025) Decoding the ability of Helicobacter pylori to evade immune recognition and cause disease. Cell Mol Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.jcmgh.2025.101470","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"5104_CR31","doi-asserted-by":"publisher","first-page":"2409924","DOI":"10.1080\/19490976.2024.2409924","volume":"16","author":"WY Sit","year":"2024","unstructured":"Sit WY, Cheng ML, Chen TJ et al (2024) Helicobacter pylori PldA modulates TNFR1-mediated p38 signaling pathways to regulate macrophage responses for its survival. Gut Microbes 16(1):2409924. https:\/\/doi.org\/10.1080\/19490976.2024.2409924","journal-title":"Gut Microbes"},{"issue":"4","key":"5104_CR32","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/ni.3691","volume":"18","author":"AV Villarino","year":"2017","unstructured":"Villarino AV, Kanno Y, O\u2019Shea JJ (2017) Mechanisms and consequences of Jak-STAT signaling in the immune system. Nat Immunol 18(4):374\u2013384. https:\/\/doi.org\/10.1038\/ni.3691","journal-title":"Nat Immunol"},{"issue":"2","key":"5104_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.canlet.2013.08.016","volume":"345","author":"F Wang","year":"2014","unstructured":"Wang F, Meng W, Wang B, Qiao L (2014) Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett 345(2):196\u2013202. https:\/\/doi.org\/10.1016\/j.canlet.2013.08.016","journal-title":"Cancer Lett"},{"key":"5104_CR34","doi-asserted-by":"publisher","first-page":"1593727","DOI":"10.3389\/fimmu.2025.1593727","volume":"16","author":"X Wu","year":"2025","unstructured":"Wu X, Gou G, Wen M et al (2025) The immunoregulatory role of helper T cells in Helicobacter pylori infection. Front Immunol 16:1593727. https:\/\/doi.org\/10.3389\/fimmu.2025.1593727","journal-title":"Front Immunol"},{"issue":"1","key":"5104_CR35","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1186\/s12885-025-14246-1","volume":"25","author":"S Xu","year":"2025","unstructured":"Xu S, Chen Z, Chen X et al (2025) Interplay of disulfidptosis and the tumor microenvironment across cancers: implications for prognosis and therapeutic responses. BMC Cancer 25(1):1113. https:\/\/doi.org\/10.1186\/s12885-025-14246-1","journal-title":"BMC Cancer"},{"issue":"1","key":"5104_CR36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue C, Yao Q, Gu X et al (2023) Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Ther 8(1):204. https:\/\/doi.org\/10.1038\/s41392-023-01468-7","journal-title":"Signal Transduct Target Ther"},{"key":"5104_CR37","doi-asserted-by":"publisher","first-page":"118903","DOI":"10.1016\/j.lfs.2020.118903","volume":"266","author":"T Yang","year":"2021","unstructured":"Yang T, Wang R, Liu H et al (2021) Berberine regulates macrophage polarization through IL-4-STAT6 signaling pathway in Helicobacter pylori-induced chronic atrophic gastritis. Life Sci 266:118903. https:\/\/doi.org\/10.1016\/j.lfs.2020.118903","journal-title":"Life Sci"},{"key":"5104_CR38","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.2147\/JIR.S509245","volume":"18","author":"S Yang","year":"2025","unstructured":"Yang S, Liu H, Zheng Y et al (2025) The role of PLIN3 in prognosis and tumor-associated macrophage infiltration: a pan-cancer analysis. J Inflamm Res 18:3757\u20133777. https:\/\/doi.org\/10.2147\/JIR.S509245","journal-title":"J Inflamm Res"},{"issue":"10","key":"5104_CR39","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/s41419-018-0982-2","volume":"9","author":"Y Yu","year":"2018","unstructured":"Yu Y, Zhu S, Li P, Min L, Zhang S (2018) Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract. Cell Death Dis 9(10):961. https:\/\/doi.org\/10.1038\/s41419-018-0982-2","journal-title":"Cell Death Dis"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05104-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-05104-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05104-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:35:49Z","timestamp":1792989349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-05104-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["5104"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-05104-0","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"567"}}